Annual D&A
$43.55 M
+$5.03 M+13.04%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual depreciation & amortization is $43.55 million, with the most recent change of +$5.03 million (+13.04%) on December 31, 2024.
- During the last 3 years, TVTX annual D&A has risen by +$30.81 million (+241.72%).
- TVTX annual D&A is now at all-time high.
Performance
TVTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$12.09 M
+$852.00 K+7.58%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly depreciation & amortization is $12.09 million, with the most recent change of +$852.00 thousand (+7.58%) on December 1, 2024.
- Over the past year, TVTX quarterly D&A has increased by +$2.60 million (+27.43%).
- TVTX quarterly D&A is now at all-time high.
Performance
TVTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$43.55 M
+$2.60 M+6.36%
December 1, 2024
Summary
- As of February 26, 2025, TVTX TTM depreciation & amortization is $43.55 million, with the most recent change of +$2.60 million (+6.36%) on December 1, 2024.
- Over the past year, TVTX TTM D&A has increased by +$5.03 million (+13.04%).
- TVTX TTM D&A is now at all-time high.
Performance
TVTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TVTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.0% | +27.4% | +13.0% |
| 3 y3 years | +241.7% | +27.4% | +13.0% |
| 5 y5 years | +113.4% | +27.4% | +13.0% |
TVTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +241.7% | at high | +254.6% | at high | +561.3% |
| 5 y | 5-year | at high | +241.7% | at high | +254.6% | at high | +561.3% |
| alltime | all time | at high | >+9999.0% | at high | +254.6% | at high | >+9999.0% |
Travere Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $43.55 M(+13.0%) | - | - |
| Dec 2024 | - | $12.09 M(+7.6%) | $43.55 M(+6.4%) |
| Sep 2024 | - | $11.24 M(+8.6%) | $40.95 M(-0.6%) |
| Jun 2024 | - | $10.35 M(+4.7%) | $41.19 M(-1.4%) |
| Mar 2024 | - | $9.88 M(+4.1%) | $41.79 M(+8.5%) |
| Dec 2023 | $38.53 M(+86.0%) | $9.49 M(-17.3%) | $38.53 M(+9.0%) |
| Sep 2023 | - | $11.47 M(+4.8%) | $35.35 M(+53.1%) |
| Jun 2023 | - | $10.95 M(+65.4%) | $23.09 M(+14.0%) |
| Mar 2023 | - | $6.62 M(+4.9%) | $20.25 M(-2.3%) |
| Dec 2022 | $20.72 M(+62.6%) | $6.31 M(-896.0%) | $20.72 M(+214.6%) |
| Sep 2022 | - | -$793.00 K(-109.8%) | $6.59 M(-56.8%) |
| Jun 2022 | - | $8.11 M(+14.3%) | $15.25 M(+10.8%) |
| Mar 2022 | - | $7.09 M(-190.7%) | $13.76 M(+8.0%) |
| Dec 2021 | $12.75 M(-48.1%) | -$7.82 M(-199.3%) | $12.75 M(-53.1%) |
| Sep 2021 | - | $7.87 M(+18.9%) | $27.20 M(+5.6%) |
| Jun 2021 | - | $6.62 M(+9.0%) | $25.77 M(+3.1%) |
| Mar 2021 | - | $6.07 M(-8.4%) | $25.00 M(+1.7%) |
| Dec 2020 | $24.58 M(+20.4%) | $6.63 M(+3.0%) | $24.58 M(+5.8%) |
| Sep 2020 | - | $6.44 M(+10.0%) | $23.24 M(+4.8%) |
| Jun 2020 | - | $5.85 M(+3.4%) | $22.17 M(+4.8%) |
| Mar 2020 | - | $5.66 M(+6.9%) | $21.16 M(+3.7%) |
| Dec 2019 | $20.41 M(+9.3%) | $5.29 M(-1.6%) | $20.41 M(+2.1%) |
| Sep 2019 | - | $5.38 M(+11.1%) | $20.00 M(+3.0%) |
| Jun 2019 | - | $4.84 M(-1.2%) | $19.42 M(+1.0%) |
| Mar 2019 | - | $4.90 M(+0.5%) | $19.22 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $18.67 M(+4.9%) | $4.88 M(+1.7%) | $18.67 M(+2.3%) |
| Sep 2018 | - | $4.80 M(+3.3%) | $18.26 M(+1.0%) |
| Jun 2018 | - | $4.64 M(+6.8%) | $18.07 M(+1.2%) |
| Mar 2018 | - | $4.35 M(-2.7%) | $17.87 M(+0.4%) |
| Dec 2017 | $17.80 M(+10.3%) | $4.47 M(-3.2%) | $17.80 M(+1.6%) |
| Sep 2017 | - | $4.62 M(+4.0%) | $17.52 M(+3.1%) |
| Jun 2017 | - | $4.44 M(+3.6%) | $17.00 M(+2.8%) |
| Mar 2017 | - | $4.28 M(+2.4%) | $16.53 M(+2.4%) |
| Dec 2016 | $16.14 M(+20.5%) | $4.18 M(+2.1%) | $16.14 M(+1.3%) |
| Sep 2016 | - | $4.09 M(+3.2%) | $15.93 M(+1.4%) |
| Jun 2016 | - | $3.97 M(+2.0%) | $15.71 M(+1.4%) |
| Mar 2016 | - | $3.89 M(-2.1%) | $15.50 M(+15.8%) |
| Dec 2015 | $13.39 M(+148.0%) | $3.98 M(+2.4%) | $13.39 M(+18.8%) |
| Sep 2015 | - | $3.88 M(+3.3%) | $11.28 M(+22.0%) |
| Jun 2015 | - | $3.76 M(+111.2%) | $9.24 M(+31.1%) |
| Mar 2015 | - | $1.78 M(-4.3%) | $7.05 M(+30.6%) |
| Dec 2014 | $5.40 M(+2400.5%) | $1.86 M(+0.4%) | $5.40 M(+50.0%) |
| Sep 2014 | - | $1.85 M(+18.2%) | $3.60 M(+99.6%) |
| Jun 2014 | - | $1.57 M(+1131.0%) | $1.80 M(+519.8%) |
| Mar 2014 | - | $127.20 K(+123.6%) | $291.00 K(+34.7%) |
| Dec 2013 | $216.00 K(+72.9%) | $56.90 K(+5.8%) | $216.00 K(+35.8%) |
| Sep 2013 | - | $53.80 K(+1.3%) | $159.10 K(+51.1%) |
| Jun 2013 | - | $53.10 K(+1.7%) | $105.30 K(+101.7%) |
| Mar 2013 | - | $52.20 K | $52.20 K |
| Dec 2012 | $124.90 K | - | - |
FAQ
- What is Travere Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Travere Therapeutics?
- What is Travere Therapeutics annual D&A year-on-year change?
- What is Travere Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Travere Therapeutics?
- What is Travere Therapeutics quarterly D&A year-on-year change?
- What is Travere Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Travere Therapeutics?
- What is Travere Therapeutics TTM D&A year-on-year change?
What is Travere Therapeutics annual depreciation & amortization?
The current annual D&A of TVTX is $43.55 M
What is the all time high annual D&A for Travere Therapeutics?
Travere Therapeutics all-time high annual depreciation & amortization is $43.55 M
What is Travere Therapeutics annual D&A year-on-year change?
Over the past year, TVTX annual depreciation & amortization has changed by +$5.03 M (+13.04%)
What is Travere Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of TVTX is $12.09 M
What is the all time high quarterly D&A for Travere Therapeutics?
Travere Therapeutics all-time high quarterly depreciation & amortization is $12.09 M
What is Travere Therapeutics quarterly D&A year-on-year change?
Over the past year, TVTX quarterly depreciation & amortization has changed by +$2.60 M (+27.43%)
What is Travere Therapeutics TTM depreciation & amortization?
The current TTM D&A of TVTX is $43.55 M
What is the all time high TTM D&A for Travere Therapeutics?
Travere Therapeutics all-time high TTM depreciation & amortization is $43.55 M
What is Travere Therapeutics TTM D&A year-on-year change?
Over the past year, TVTX TTM depreciation & amortization has changed by +$5.03 M (+13.04%)